Cancer Family
B-Cell Proliferation of Uncertain Malignant Potential
CI-CAN-00000071Explore in graph →
HematologicNon-malignant2 active trials
- NCIt
- C7182
Loading cancer entity…
Cancer Family
CI-CAN-00000071Explore in graph →
Clinical trials
83 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT01676805 | Tissue Collection for Studies of Lymph Cancer | recruiting | — | 1,295 | National Cancer Institute (NCI)NIH | 2 | Sep 28, 2026 | clinicaltrials |
| NCT01815749 | Genetically Modified T-cell Infusion Following Peripheral Blood Stem Cell Transplant in Treating Patients With Recurrent or High-Risk Non-Hodgkin Lymphoma | active not recruiting | Phase 1 | 30 | City of Hope Medical CenterOTHER | 1 | Jun 25, 2026 | clinicaltrials |
| NCT03038672 | Nivolumab With or Without Varlilumab in Treating Patients With Relapsed or Refractory Aggressive B-cell Lymphomas | active not recruiting | Phase 2 | 54 | National Cancer Institute (NCI)NIH | 1 | May 12, 2026 | clinicaltrials |
| NCT01199562 |
Data updated 2 days agoSource updated Sep 28, 2026source: clinicaltrials
| active not recruiting |
| — |
| 153 |
| City of Hope Medical CenterOTHER |
| 1 |
| Jan 28, 2026 |
| clinicaltrials |